BBIO vs EXEL
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 02, 2026
BBIO
EXEL
Investment Advisor Scores
EXEL
AI Analyst Insights
Detailed Metrics Comparison
| Metric | BBIO | EXEL | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 0 | 17.5131 | Tie |
| PEG Ratio | 0 | 2.2685 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 66.8% | 10.0% | BBIO |
| Earnings Growth | 0.0% | 43.6% | EXEL |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 55.7/100 | 47.2/100 | BBIO |
| Profit Margin | -124.4% | 35.1% | EXEL |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
BBIO
MarkupPrice above SMA50, rising 50-day trend (7.8% over 20 days), RSI 51
EXEL
NeutralMixed signals - no dominant trend phase, RSI 42
Fundamentals Snapshot
| Metric | BBIO | EXEL |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 140.8 | 13.1 |
| Trailing P/E | — | 18.5 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.7% | 0.1% |
| Gross Margin | 1.0% | 1.0% |
| Operating Margin | -0.5% | 0.4% |
| EPS | -3.67 | 3.02 |
| Dividend Yield | — | — |